S.P. Menting

890 citations

13 papers · 585 indexed · h-index 9

Impact in

Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
- IL-33, ST2, and ILC Pathways
- Immune Cell Function and Interaction
Dermatology top 2%
- Dermatology and Skin Diseases

Papers in

Dermatology 6
- Dermatology and Skin Diseases 6
Immunology 11
- Psoriasis: Treatment and Pathogenesis 10

Co-authors: Phyllis I. Spuls E.M.G.J. de Jong Marcel B. M. Teunissen Liv Eidsmo J. Marius Munneke M.W.D. Brouwer Mette D. Hazenberg Stanley Cheuk
Journals: Journal of Investigative Dermatology (3 papers)Journal of Dermatological Treatment (2 papers)Journal of the European Academy of Dermatology and Venereology (2 papers)JAMA Dermatology (2 papers)The Oncologist (1 paper)
Partner nations: Netherlands Belgium Singapore

In The Last Decade

S.P. Menting

13 papers receiving 580 citations

Peers

Countries citing papers authored by S.P. Menting

Since Specialization

Citations

This map shows the geographic impact of S.P. Menting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.P. Menting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.P. Menting more than expected).

Fields of papers citing papers by S.P. Menting

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.P. Menting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.P. Menting. The network helps show where S.P. Menting may publish in the future.

Co-authorship network

The 25 scholars most cited alongside S.P. Menting, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S.P. Menting Line = papers co-authored together S.P. Menting links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three‐year follow‐up data of a single‐blind randomized controlled trial Journal of the European Academy of Dermatology and Venereology ·Y‐H Tai, G. E. van der Kraaij, Stacy Scofield- Kaplan, Wouter Ouwerkerk, J. M. P. A. van den Reek, S.P. Menting, Errol P. Prens, Theo Rispens, Annick de Vries, E.M.G.J. de Jong, Jo Lambert, Martijn B. A. van Doorn, Phyllis I. Spuls	2023	5
2	Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic–Pharmacodynamic Modeling Journal of Investigative Dermatology ·Y‐H Tai, Teraze A. Youssef, G. E. van der Kraaij, Annelie H. Musters, Stacy Scofield- Kaplan, S.P. Menting, Theo Rispens, Annick de Vries, Martijn B. A. van Doorn, Errol P. Prens, Jo Lambert, J. M. P. A. van den Reek, E.M.G.J. de Jong, Ron A. A. Mathôt, Phyllis I. Spuls	2023	3
3	Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled Trial Journal of Investigative Dermatology ·G. E. van der Kraaij, Stacy Scofield- Kaplan, J. M. P. A. van den Reek, S.P. Menting, Annelie H. Musters, Barbara A. Hutten, Menno A. de Rie, Wouter Ouwerkerk, EYAL AVIV, Errol P. Prens, Theo Rispens, Annick de Vries, E.M.G.J. de Jong, K. G. Specht, Jo Lambert, Martijn B. A. van Doorn, Phyllis I. Spuls	2022	15
4	National consensus on biologic dose reduction in psoriasis: a modified eDelphi procedure Journal of Dermatological Treatment ·David S. Thylur, Constanze Cholmakov-Bodechtel, W. A. van Enst, S.P. Menting, Marieke M.B. Seyger, Angeliki Maliri, H. J. Jiménez-Gonz ́lez-, Arwen H. Pieterse, J. M. P. A. van den Reek, E.M.G.J. de Jong	2022	1
5	Methotrexate dosing regimen for plaque-type psoriasis: an update of a systematic review Journal of Dermatological Treatment ·Y‐H Tai, A.C.P. De Crem, 吉田健一郎, S.P. Menting, Phyllis I. Spuls	2022	10
6	Cutaneous Toxicity After Chemoradiotherapy and PD-L1 Inhibition in Two Patients with Esophageal Adenocarcinoma: More than Meets the Eye The Oncologist ·Tom van den Ende, S.P. Menting, Carmen A. Ambarus, Martijn G.H. van Oijen, Hanneke W.M. van Laarhoven	2019	3
7	Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial Trials ·Stacy Scofield- Kaplan, S.P. Menting, Julio S. L. T. Milit�o, Miriam Borja, Barbara A. Hutten, Errol P. Prens, E.M.G.J. de Jong, M Adam, Phyllis I. Spuls	2017	16
8	Methotrexate Dosing Regimen for Plaque-type Psoriasis: A Systematic Review of the Use of Test-dose, Start-dose, Dosing Scheme, Dose Adjustments, Maximum Dose and Folic Acid Supplementation Acta Dermato Venereologica ·S.P. Menting, Liliana Britos, Jacqueline Limpens, Lotty Hooft, Phyllis I. Spuls	2015	31
9	Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis JAMA Dermatology ·S.P. Menting, Chenfeng Lu, Mieke F. Pouw, J.M.P.A. van den Reek, Dinda Puteri Pertiwi, Hugo Boonen, E.M.G.J. de Jong, Phyllis I. Spuls, Jo Lambert	2015	73
10	An increased risk of non‐melanoma skin cancer during TNF‐inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease‐related factors Journal of the European Academy of Dermatology and Venereology ·P.P.M. van Lümig, S.P. Menting, J. M. P. A. van den Reek, Phyllis I. Spuls, Piet L. C. M. van Riel, P.C.M. van de Kerkhof, Jaap Fransen, Wietske Kievit, E.M.G.J. de Jong	2014	51
11	Composition of Innate Lymphoid Cell Subsets in the Human Skin: Enrichment of NCR+ ILC3 in Lesional Skin and Blood of Psoriasis Patients Journal of Investigative Dermatology ·Marcel B. M. Teunissen, J. Marius Munneke, Jochem H. Bernink, Phyllis I. Spuls, Hermanson Terhi, Anje A. te Velde, Stanley Cheuk, M.W.D. Brouwer, S.P. Menting, Liv Eidsmo, Hergen Spits, Mette D. Hazenberg, Jenny Mjösberg	2014	253
12	Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: a single‐centre database analysis British Journal of Dermatology ·S.P. Menting, Amith Sitaram, Jesus Armando Sanchez Carranza, Menno A. de Rie, Lotty Hooft, Phyllis I. Spuls	2014	57
13	Extent and Consequences of Antibody Formation Against Adalimumab in Patients With Psoriasis JAMA Dermatology ·S.P. Menting, P.P.M. van Lümig, 蔡芹, J.M.P.A. van den Reek, Desirée van der Kleij, E.M.G.J. de Jong, Phyllis I. Spuls, L.L.A. Lecluse	2013	67

About S.P. Menting

S.P. Menting is a scholar working on Dermatology, Immunology, Pathology and Forensic Medicine, Rheumatology and Hematology, having authored 13 papers that have together received 585 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (10 papers), Dermatology and Skin Diseases (6 papers), Autoimmune Bullous Skin Diseases (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Delphi Technique in Research (1 paper), Microscopic Colitis (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Immunology (504 citations), Dermatology (192 citations), Rheumatology (100 citations), Hematology (57 citations) and Surgery (129 citations). S.P. Menting has collaborated with scholars based in Netherlands, Belgium and Singapore. Frequent co-authors include Phyllis I. Spuls, E.M.G.J. de Jong, Marcel B. M. Teunissen, Liv Eidsmo, J. Marius Munneke, M.W.D. Brouwer, Mette D. Hazenberg, Stanley Cheuk, Jenny Mjösberg and Jochem H. Bernink. Their work appears in journals such as Journal of Investigative Dermatology, Journal of Dermatological Treatment, Journal of the European Academy of Dermatology and Venereology, JAMA Dermatology and The Oncologist.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact